Vaccine Products

    François   Espanola   العربية    中國  Thai        

 
 Home   About us   Patents   Vaccines Research  Clinical Trials Facilities   Investment  Global Health   Contact us 

SYMPTOMS OF BACTERIAL  MENINGITIS DISEASE

The common signs and symptoms of meningitis and septicemia. Others can include rapid breathing, diarrhea, stomach cramps and a rash that does not fade under pressure. In babies, check if the soft spot (fontanelle) on the top of the head is tense or bulging.

TODDLERS

High fever vomiting, diarrhea

High pitched moaning, cry

Blank, Pale, blotchy complexion

Baby dislike being handled

Difficult to wake or lethargic

CHILDREN & ADULTS

High fever, vomiting

Diarrhea

Severe headache

Neck stiffness

Joint or muscle pains

Dislike of bright lights

Drowsiness

Fits

 

enlarge

PRESS RELEASE

 

JN International Medical Corporation Provides Vaccine for Meningococcal Meningitis Disease Outbreak in India  

VACCINE PRODUCTS Page 

 

Vaccines meet the requirements established by the World Health Organization and U.S. and European Pharmacopoeia.

 

Meningococcal meningitis A/C/Y/W135 Polysaccharide Vaccine Freeze dried (Serotypes A,C,Y,W-135)

1 or 10-dose

  

  NmVac-4 A/C/Y/W-135

~  Meningococcal Polysaccharide vaccine to protect from Meningococcal meningitis serogroups A, C, Y & W135 offers 18-months protective immunity. The vaccine is given to persons 5 through 55 years of age to protect from Neisseria meningitidis serogroups A, C, Y and W-135.  

The vaccine is made from bacterial capsular polysaccharides through fermentation of each individual serogroup of Neisseria meningitides in bioreactors. Then the polysaccharides are purified, formulated and lyophilized using preservatives and stabilizers to make a vaccine product.

PRODUCT DETAILS IN WIKIPEDIA

PATENT:  US 7491517

  Meningococcal Vaccine Products are for Africa and Hajj.  Clinically proven to be safe and efficacious; tests on 750 adults in Niger and Burkina Faso for a period of 52-weeks.

 The product is ready for sale - for export only.
   

PRODUCT BROCHUREAdobe Acrobat [pdf] file

Stock : 1-3 million doses. (2009 - 2010)

Credit offer for 1 year on confirmed LC. 

At present, 1-dose formats are available. 

Contact us:

Meningococcal meningitis A/C/Y/W135 Diphtheria Toxoid Conjugate Vaccine - Liquid (Serotypes A,C,Y,W-135)

10-dose  1-dose      

 

 

NmVac-4 A/C/Y/W-135-DT

Meningococcal meningitis polysaccharide serogroups A.C.Y.W-135 Diphtheria (DT) conjugate vaccine. The product is specially designed and formulated to be used in developing countries for protecting populations during Meningitis disease epidemics. meningococcal meningitis serogroups A/C/Y/W-135 DT conjugated vaccine for infants, children and adults offers 3 years protective immunity. The vaccine is given to persons 2 through 55 years of age to protect from Neisseria meningitidis serogroups A, C, Y and W-135.  

 

PRODUCT DETAILS IN WIKIPEDIA

PATENT:  US 7491517

  Meningococcal DT conjugate Vaccine Product Clinically proven to be safe and efficacious; tests on 100 children in North Ivory Coast for a period of 48-weeks. 

Expected to be in the market in 2011
 

PRODUCT BROCHUREAdobe Acrobat [pdf] file

Meningococcal meningitis A & C Vaccine - Freeze dried

 

(Serotypes A+C vaccine) for Adults and Children - Meningococcal A&C Vaccine

 NOT A JN PRODUCT 

 

Meningococcal meningitis A&C Vaccine Product Clinically proven to be safe and efficacious since 30 years.    

NO ON-LINE ORDERS - e-MAIL THE REQUEST 

 

 

Vaccines product orders strictly accepted from Africa, South East Asia, and Middle East -  Not for sale in the United States America

 
 

MenVac A&C vaccine

 

   

Stock : 1-3 million doses.

Credit offer for 1 year on confirmed LC. 

 PRODUCT BROCHUREAdobe Acrobat [pdf] file 

Meningococcal meningitis A & C Vaccine - Freeze dried

 

(Serotypes A&C vaccine) for Adults and Children - Meningococcal A&C Vaccine

 

  Customer Information

  • Stock =  3,000,000 doses (2008-2009)

  • Cold Storage facility: Burkina Faso and Singapore

  • Customers should prove to show Cold Chain handling and storage to be qualified for purchase.

  • - Ref - WHO guidelines

  • Contact us for volume discount and registration documents.

  • Credit up to 90-120 days on LC for qualified customers. 

  • Minimum order 100,000 doses;

  • Special discount prices offers for NGO's.  

  • The product is registered in Ivory Coast, Burkina Faso, Niger, Togo, Benin, Senegal and other West Africa

  • This product is registered in some of the South East Asia countries.   

  • Customers need to register in other areas please contact us for registration documents and samples.

Third party WHO prequalified vaccines: Polio, Rabies, DTP, DTP+Hb, and Hepatitis B are offered by our Africa business centers. XXXXXX Contact us:

©1998-2005 JN International, Inc. All rights reserved